{"schema_version":"secwatch.filing_event.v1","accession":"0001625101-21-000044","form_type":"8-K","ticker":"PLSE","cik":"0001625101","company_name":"PULSE BIOSCIENCES, INC.","filed_at":"2021-08-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.917253+00:00","generated_at":"2026-06-29T08:39:46.089855+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Pulse Biosciences appoints Mitchell E. Levinson as Chief Strategy Officer","bullets":["Appointment effective August 19, 2021; Levinson continues as board member.","He brings 30+ years in med device, co-founded Cerebrotech and was early Zeltiq employee.","Role is newly created; company plans multi-specialty expansion using CellFX platform.","No financial guidance or earnings changes announced in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001625101-21-000044","json":"https://secwatch.observer/filing/0001625101-21-000044.json","markdown":"https://secwatch.observer/filing/0001625101-21-000044.md","text":"https://secwatch.observer/filing/0001625101-21-000044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625101/000162510121000044/0001625101-21-000044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625101/000162510121000044/plse-20210819x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T08:39:46.089855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f293df3384","claim":"Mitchell E. Levinson was appointed as Chief Strategy Officer at PULSE BIOSCIENCES, INC..","evidence_excerpt":"On August 19, 2021, Pulse Biosciences, Inc. (the “Company”) announced the appointment of Mitchell E. Levinson to the newly created role of Chief Strategy Officer, effective immediately, in addition to the continuation of his role as a member of the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1625101/000162510121000044/0001625101-21-000044-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Strategy Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}